{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:29:09Z","timestamp":1788805749432,"version":"build-2803163510"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Adenosine deaminase (ADA) is an enzyme involved in purine metabolism and it is a marker of nonspecific T-cell activation. Few studies have shown high levels of ADA in the epidermis and sera of psoriatic patients. Other inflammatory markers such as high-sensitive C-reactive protein (hsCRP), erythrocyte sedimentation rate (ESR), and serum uric acid (SUA) have shown correlations with psoriasis area severity index (PASI) score. The correlation between ADA and PASI score is still a matter of debate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate serum ADA, hsCRP, SUA, and ESR in psoriatic patients and their correlation with PASI score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>This study included 60 psoriatic patients divided according to PASI score into three groups (mild, moderate, and severe) each containing 20 patients. PASI score &lt;10 was defined as mild, (10\u201320) moderate, and &gt;20 severe. Twenty healthy subjects of matched age and sex were included as control. Serum ADA, hsCRP, SUA, and ESR were evaluated for patients and controls. Correlations of ADA, hsCRP, SUA, and ESR with PASI scores were done.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>While ADA, hsCRP, SUA, and ESR showed a significant increase in psoriatic patients compared with that of the controls (P&lt;001), they showed no significant difference between different psoriatic groups (P&gt;0.05) and no correlations with PASI score (P&gt;0.05). The frequency of joint affection increased with increasing severity of psoriasis (5%, 10%, and 25% in mild, moderate, and severe psoriasis, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Serum ADA, hsCRP, SUA, and ESR showed higher levels among psoriatic patients than in controls. The increased ADA in psoriatic patients supports the role of T-cell activation and proliferative disorder in the pathogenesis of psoriasis. No significant correlations were found between these biomarkers and PASI score. Further studies are needed to validate these biomarkers as diagnostic and prognostic factors in psoriasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_420_17","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:11:28Z","timestamp":1559020288000},"page":"207-212","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of Serum Adenosine Deaminase and Inflammatory Markers in Psoriatic Patients"],"prefix":"10.4103","volume":"64","author":[{"given":"Yousry M","family":"Moustafa","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, Faculty of Medicine, Mansoura University, Mansoura, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa Ahmed","family":"Elsaied","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Faculty of Medicine, Mansoura University, Mansoura, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan M","family":"Abd-Elaaty","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha A","family":"Elsayed","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, Faculty of Medicine, Mansoura University, Mansoura, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250921","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The inflammatory response in psoriasis: A comprehensive review","volume":"50","author":"Deng","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"R2-20250921","first-page":"277","article-title":"Characterization of human adenosine deaminase","volume":"48","author":"Kelley","year":"1977","journal-title":"Ciba Found Symp"},{"key":"R3-20250921","first-page":"3","article-title":"Metabolism of purine compounds in psoriasis","volume":"3","author":"Tikhonov","year":"1998","journal-title":"Klin Lab Diagn"},{"key":"R4-20250921","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF00417203","article-title":"Adenosine deaminase in human epidermis from healthy and psoriatic subjects","volume":"275","author":"Koizumi","year":"1983","journal-title":"Arch Dermatol Res"},{"key":"R5-20250921","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1365-2133.2001.04221.x","article-title":"Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis","volume":"144","author":"K\u00f6se","year":"2001","journal-title":"Br J Dermatol"},{"key":"R6-20250921","first-page":"274","article-title":"Serum adenosine deaminase levels in patients with psoriasis: A prospective case-control study","volume":"10","author":"Bukulmez","year":"2000","journal-title":"Eur J Dermatol"},{"key":"R7-20250921","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/clinchem\/47.3.403","article-title":"High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease","volume":"47","author":"Rifai","year":"2001","journal-title":"Clin Chem"},{"key":"R8-20250921","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000442749","article-title":"Serum biomarkers of allergic contact dermatitis: A pilot study","volume":"168","author":"Zinkevi\u010dien\u0117","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"R9-20250921","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1590\/abd1806-4841.20153352","article-title":"Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides","volume":"90","author":"Cengiz","year":"2015","journal-title":"An Bras Dermatol"},{"key":"R10-20250921","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1159\/000446021","article-title":"Leukocyte profile in peripheral blood and neutrophil-lymphocyte ratio in hidradenitis suppurativa: A Comparative cross-sectional study of 462 cases","volume":"232","author":"Miller","year":"2016","journal-title":"Dermatology"},{"key":"R11-20250921","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5603\/FHC.2012.0025","article-title":"Biochemical markers of psoriasis as a metabolic disease","volume":"50","author":"Gerkowicz","year":"2012","journal-title":"Folia Histochem Cytobiol"},{"key":"R12-20250921","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jdv.12257","article-title":"C-reactive protein in psoriasis: A review of the literature","volume":"28","author":"Beygi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R13-20250921","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-012-8308-0","article-title":"Inflammation, atherosclerosis, and psoriasis","volume":"44","author":"Siegel","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"R14-20250921","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00403-008-0887-5","article-title":"The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis","volume":"300","author":"Ohtsuka","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"R15-20250921","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1365-2133.2012.10883.x","article-title":"Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis","volume":"166","author":"Roman\u00ed","year":"2012","journal-title":"Br J Dermatol"},{"key":"R16-20250921","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2133.2008.08628.x","article-title":"Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis","volume":"159","author":"Strober","year":"2008","journal-title":"Br J Dermatol"},{"key":"R17-20250921","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2013.08.023","article-title":"Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: A meta-analysis of prospective studies","volume":"231","author":"Zhao","year":"2013","journal-title":"Atherosclerosis"},{"key":"R18-20250921","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/annrheumdis-2014-205212","article-title":"Psoriasis, psoriatic arthritis and risk of gout in US men and women","volume":"74","author":"Merola","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R19-20250921","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.05984.x","article-title":"The inflammatory response in mild and in severe psoriasis","volume":"150","author":"Rocha-Pereira","year":"2004","journal-title":"Br J Dermatol"},{"key":"R20-20250921","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1346-8138.13212","article-title":"Detection of asymptomatic enthesitis in psoriasis patients: An onset of psoriatic arthritis?","volume":"43","author":"Takata","year":"2016","journal-title":"J Dermatol"},{"key":"R21-20250921","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1523-1747.ep12384205","article-title":"Patient measurement of psoriasis disease severity with a structured instrument","volume":"102","author":"Fleischer","year":"1994","journal-title":"J Invest Dermatol"},{"key":"R22-20250921","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jdds.2015.05.002","article-title":"Psoriasis: Correlation between severity index (PASI) and quality of life index (DLQI) based on the type of treatment","volume":"20","author":"Raddadi","year":"2016","journal-title":"J Dermatol Dermatol Surg"},{"key":"R24-20250921","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0019-5154.48977","article-title":"Current concepts in the pathogenesis of psoriasis","volume":"54","author":"Das","year":"2009","journal-title":"Indian J Dermatol"},{"key":"R25-20250921","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1468-3083.2009.03416.x","article-title":"Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis","volume":"24","author":"Hashemi","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R26-20250921","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14712\/18059694.2017.119","article-title":"Serum adenosine deaminase activity in monitoring disease activity and response to therapy in severe psoriasis","volume":"49","author":"Erbagci","year":"2006","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"R27-20250921","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-4632.2010.04799.x","article-title":"CD26\/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy","volume":"50","author":"Y\u0131ld\u0131r\u0131m","year":"2011","journal-title":"Int J Dermatol"},{"key":"R28-20250921","first-page":"293","article-title":"Adenosine-deaminase (ADA) activity in psoriasis (A preliminary study)","volume":"54","author":"Chaudhry","year":"1988","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R29-20250921","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2340\/0001555572410412","article-title":"Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia","volume":"72","author":"Koizumi","year":"1992","journal-title":"Acta Derm Venereol"},{"issue":"Suppl 2","key":"R30-20250921","doi-asserted-by":"crossref","first-page":"ii65","DOI":"10.1136\/ard.2004.031237","article-title":"Psoriasis assessment tools in clinical trials","volume":"64","author":"Feldman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R31-20250921","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1468-3083.2009.03527.x","article-title":"C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy","volume":"24","author":"Coimbra","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R32-20250921","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1111\/ijd.13196","article-title":"Effect of antipsoriatic therapy on oxidative stress index and sialic acid levels in patients with psoriasis","volume":"55","author":"Rajappa","year":"2016","journal-title":"Int J Dermatol"},{"key":"R33-20250921","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1468-3083.2010.03947.x","article-title":"Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: Results of a prospective longitudinal observational study","volume":"25","author":"Boehncke","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R34-20250921","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12291-011-0132-4","article-title":"C-reactive protein and uric acid levels in patients with psoriasis","volume":"26","author":"Isha","year":"2011","journal-title":"Indian J Clin Biochem"},{"key":"R35-20250921","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/ard.40.1.66","article-title":"Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis","volume":"40","author":"Laurent","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"R36-20250921","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaad.2013.09.005","article-title":"Hyperuricemia in patients with chronic plaque psoriasis","volume":"70","author":"Gisondi","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R37-20250921","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","article-title":"Adenosine: An endogenous regulator of innate immunity","volume":"25","author":"Hask\u00f3","year":"2004","journal-title":"Trends Immunol"},{"key":"R38-20250921","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000372-198100340-00014","article-title":"Uric acid in the etiology of psoriasis","volume":"3","author":"Goldman","year":"1981","journal-title":"Am J Dermatopathol"},{"key":"R39-20250921","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2230.2010.03988.x","article-title":"Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis","volume":"36","author":"Kwon","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"R40-20250921","first-page":"132","article-title":"Hemoglobin content and sedimentation properties of erythrocytes in psoriasis","volume":"18","author":"Bajaj","year":"2008","journal-title":"J Pak Assoc Derma"},{"key":"R41-20250921","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2230.2004.01450.x","article-title":"Changes in erythrocyte microrheology in patients with psoriasis","volume":"29","author":"G\u00f3rnicki","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"R42-20250921","first-page":"18","article-title":"Serum proteins, trace metals and phosphatases in psoriasis","volume":"60","author":"Bhatnagar","year":"1994","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R43-20250921","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11926-015-0540-1","article-title":"Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: A review of available evidence","volume":"17","author":"Ogdie","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R44-20250921","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R45-20250921","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"R46-20250921","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1586\/1744666X.2014.905741","article-title":"Predictors for clinical outcome in psoriatic arthritis \u2013 What have we learned from cohort studies?","volume":"10","author":"Eder","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"R47-20250921","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/bjd.12285","article-title":"Platelet activation: A link between psoriasis per se and subclinical atherosclerosis \u2013 A case-control study","volume":"169","author":"Saleh","year":"2013","journal-title":"Br J Dermatol"},{"key":"R48-20250921","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3349\/ymj.2015.56.3.712","article-title":"Mean platelet volume is elevated in patients with psoriasis vulgaris","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med J"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00076423-201964030-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:42:33Z","timestamp":1787067753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00076423-201964030-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_420_17","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"2017-09-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}